Program In Cellular News Today

Assistant Professor – Tenure Track, PCMM Boston Children's Hospital, Harvard Medical School Genetics job in Boston, Massachusetts (US) with Boston Children's Hospital - Program in Cellular and Molecular Medicine. Apply Today.

超微肽拥抱病毒 搞定全部变异株新冠克星登场！“死亡拥抱”搞定全部变异株2022-9-2602:20PM| 发布者: 迷恋の米AllSARS-CoV-2variantsblocked...

Investigators studying lung cells have discovered that the normal repair process that occurs after lung disease or injury appears to be incomplete but still ongoing in patients who died of COVID-19 and non-COVID acute respiratory distress syndrome (ARDS).

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

(1) BEDMINSTER, N.J., Feb. 25, 2021 /PRNewswire/ -- Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, today announced a collaboration with Boston Childrens Hospital (https://wistar.org/) to evaluate peptidyl arginine deiminase 4 (PAD4) inhibitors under development by Jubilant Therapeutics to explore the modulation of neutrophil extracellular traps (NETosis) in preclinical models of neu...

Researchers in the laboratory of Frederick Alt of the Howard Hughes Medical Institute and Program in Cellular and Molecular Medicine (PCMM) at Children’s Hospital Boston made a groundbreaking discovery at the nexus of chromatin biology and immunology.  Their work, recently published in Nature, showed that physiological deregulation of the WAPL chromatin-maintenance factor allows developing B lymphocytes to scan linearly through very long chromosomal loops to find and join gene segments that ...